Is Kaposi’s sarcoma the end of the OX40/OX40L axis in atopic dermatitis?
The OX40/OX40L axis entered clinical development in atopic dermatitis with a strong biological rationale and early signs of durable activity. However, as the treatment landscape evolved, questions emerged about whether the magnitude of monotherapy bene…